Results from a multiple sclerosis relapse clinic.

Area of Science:

• Neurology
• Clinical Medicine
• Healthcare Management

Background:

• Multiple sclerosis (MS) relapse clinics aim for early diagnosis and management of MS relapses.
• Published outcome data from MS relapse clinics are limited, hindering understanding of their real-world utility.

Purpose of the Study:

• To analyze the outcomes of a specific MS relapse clinic over a 12-month period.
• To determine the frequency of confirmed MS relapses versus other presentations at the clinic.
• To assess the utilization of corticosteroid therapy in the context of clinic attendances.

Main Methods:

• Retrospective analysis of patient data from the Belfast Health and Social Care Trust (BHSCT) relapse clinic.
• Inclusion of all attendances over a defined 12-month period.
• Review of diagnostic criteria, including new neurological symptoms and radiological evidence of disease activity.

Main Results:

• Only 16% of attendees were diagnosed with a confirmed MS relapse.
• Pseudorelapse was identified as a more frequent reason for presentation (19%) than actual relapse.
• Corticosteroid therapy was administered in a low percentage (3%) of all attendances.

Conclusions:

• The low rate of confirmed relapses underscores the importance of thorough clinical evaluation for new neurological symptoms.
• Findings suggest a need for caution in prescribing corticosteroids for suspected MS relapses.
• The results may indicate the impact of highly effective disease-modifying therapies on relapse rates.
• Encourages publication of relapse clinic data to better characterize relapse frequency and service utility.